Evidence map›Paper›PMID 41294675›Full record

ArticleCurrent oncology (Toronto, Ont.)2025

The Cardio-Oncology Patients-What They Know and What They Should Know.

Aneta Klotzka, Barbara Gawłowska, Ewelina Chawłowska

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Aneta Klotzka1st Department of Cardiology, Poznan University of Medical Sciences, 61-848 Poznan, Poland.ORCID 0000-0003-1063-8318
Barbara GawłowskaDepartment of Preventive Medicine, Poznan University of Medical Sciences, 60-781 Poznan, Poland.
Ewelina ChawłowskaDepartment of Preventive Medicine, Poznan University of Medical Sciences, 60-781 Poznan, Poland.ORCID 0000-0002-1966-9498

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing number of patients after oncological treatment makes knowledge about potential cardiovascular complications of cancer therapy particularly important. Early recognition of symptoms enables the rapid initiation of appropriate therapy and improves outcomes. Education in this field increases awareness of the need for regular cardiology follow-up and adherence to health recommendations. It is advisable for patient education on the risk of cardiotoxicity to be included during visits with both the oncologist and the cardiologist. A self-developed questionnaire was used. It consisted of 40 questions (including 16 from the Health Behavior Scale) and 8 additional sociodemographic questions. An anonymous questionnaire was completed by 243 patients of the cardio-oncology outpatient clinic operating within the Department of Cardiology in Poland. In the survey conducted, patients were asked to define the concept of cardio-oncology; only 23.5% of respondents provided a correct answer. The highest level of awareness was observed among individuals under the age of 40 (

Indexed as

Antineoplastic AgentsCardiovascular DiseasesHealth Knowledge, Attitudes, PracticeNeoplasmsAdultAgedCardiologyCardio-OncologyCardiotoxicityFemaleHumansMaleMedical OncologyMiddle AgedPatient Education as TopicSurveys and QuestionnairesAntineoplastic Agentscancer patientscardio-oncologyhealth behaviourshealth educationphysicians

Identifiers

PMID41294675
PMCPMC12651008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.